KCM

Knoll Capital Management Portfolio holdings

AUM $141M
This Quarter Return
+1.9%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$254M
AUM Growth
+$254M
Cap. Flow
+$3.57M
Cap. Flow %
1.41%
Top 10 Hldgs %
99.59%
Holding
16
New
1
Increased
3
Reduced
2
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MDVN
1
DELISTED
MEDIVATION, INC.
MDVN
$222M 87.2% 2,244,519
AMPE
2
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$11.6M 4.57% 3,388,322 +17,500 +0.5% +$60K
TOVX icon
3
Theriva Biologics
TOVX
$3.94M
$4.97M 1.95% 3,400,816 +2,040,816 +150% +$2.98M
ARCT icon
4
Arcturus Therapeutics
ARCT
$462M
$3.23M 1.27% 865,315 +178,315 +26% +$665K
LUMO
5
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$3.08M 1.21% 77,437
KERX
6
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$2.83M 1.11% 200,000
ENLV icon
7
Enlivex Therapeutics
ENLV
$25M
$2.16M 0.85% 338,110
ADXS
8
DELISTED
Advaxis, Inc.
ADXS
$1.8M 0.71% 225,000
ASPX
9
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$1.05M 0.41% +20,000 New +$1.05M
INO icon
10
Inovio Pharmaceuticals
INO
$126M
$754K 0.3% 82,088 -20,000 -20% -$184K
ADXSW
11
DELISTED
Advaxis, Inc. Warrants
ADXSW
$467K 0.18% 112,500
GLMD icon
12
Galmed Pharmaceuticals
GLMD
$6.96M
$377K 0.15% 65,000
PVCT
13
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$160K 0.06% 200,000
NRX
14
DELISTED
NEPHROGENEX INC COM
NRX
$41K 0.02% 3,072 -46,928 -94% -$626K
CLRB icon
15
Cellectar Biosciences
CLRB
$15.5M
-14,634 Closed -$33K
NWBO
16
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
-67,035 Closed -$337K